Catheters, Indwelling Clinical Trial
Official title:
Randomized Study of the EZIO Compared to Central Venous Lines Used for Emergency Vascular Access
Multicenter randomized study to compare powered intraosseous access to standard central line access for the administration of fluids and drugs for patients in the Emergency Dept.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | September 2010 |
Est. primary completion date | September 2010 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: Over 18 years old Requires central access after peripheral access attempts have failed or are not otherwise feasible Exclusion Criteria: Fracture in target bone Not able to sign informed consent Excessive tissue or absence of adequate anatomical landmarks Known or suspected coagulopathies Pregnancy Patients in custody Patients with suspected great vessel injury Not fluid in English |
Country | Name | City | State |
---|---|---|---|
United States | Dept of Emergency Medicine, The George Washington University Medical Center | Washington | District of Columbia |
Lead Sponsor | Collaborator |
---|---|
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Vidacare Corporation |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time taken to place the device | ED visit | ||
Secondary | Incidence of complications | ED visit | ||
Secondary | Costs for each of the two methods | Ed visit |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03351725 -
Peripheral Venous Catheter Colonization Study
|
||
Completed |
NCT00272623 -
Seldinger Technique Versus Venous Cut-Down for Placement of Totally Implantable Venous Access Ports
|
N/A | |
Completed |
NCT00001518 -
A Randomized Evaluation of the Effect of Routine Normal Saline Flush Versus Heparinized Saline Solution in Groshong and Groshong PICC Catheters
|
N/A | |
Completed |
NCT00073515 -
Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices
|
Phase 2 |